Close Menu

Not So Secret

Just how private is your DNA, asks an article in Salon. The story covers the pros and cons of inadvertently making your DNA public by buying personal genome services, for instance, and how your code might eventually be misused. "The promise of these tests includes drugs that may someday be tailored to treat your illnesses," the story says. "The peril is that your personal data could circulate more widely than you expect." Blaine Bettinger, who is a customer of 23andMe, was interviewed, and he's a bit more optimistic about data handling.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.